<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="https://www.alzforum.org"  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Alzforum News</title>
 <link>https://www.alzforum.org</link>
 <description></description>
 <language>en</language>
<item>
 <title>Bespoke Shuttles: Scientists Tailor Transporters for Therapeutic Targets</title>
 <link>https://www.alzforum.org/news/conference-coverage/bespoke-shuttles-scientists-tailor-transporters-therapeutic-targets</link>
 <description>Oligonucleotide-based therapies are increasingly being fitted with shuttle constructs. Is TfR always the best choice?</description>
 <pubDate>05 Aug 2026 13:26:05 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/bespoke-shuttles-scientists-tailor-transporters-therapeutic-targets#comments</comments>
</item>
<item>
 <title>Brain Shuttles: A Coming Boom?</title>
 <link>https://www.alzforum.org/news/conference-coverage/brain-shuttles-coming-boom</link>
 <description>Extending well beyond anti-Aβ antibodies, development of brain-shuttled therapies for AD has become highly competitive. </description>
 <pubDate>05 Aug 2026 13:24:14 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/brain-shuttles-coming-boom#comments</comments>
</item>
<item>
 <title>Is a Blood Test for Cerebrovascular Disease on the Horizon?</title>
 <link>https://www.alzforum.org/news/conference-coverage/blood-test-cerebrovascular-disease-horizon</link>
 <description>Disease in the blood vessels of the brain increases a person’s risk for dementia, but there is no easy way to measure it. At AAIC, scientists reported blood marker panels that might.</description>
 <pubDate>04 Aug 2026 16:22:58 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/blood-test-cerebrovascular-disease-horizon#comments</comments>
</item>
<item>
 <title>Proteomic Meta Analysis Paints Landscape of Neurological Markers</title>
 <link>https://www.alzforum.org/news/conference-coverage/proteomic-meta-analysis-paints-landscape-neurological-markers</link>
 <description>The concentrations of 42 proteins in CSF show different patterns in 41 neurological disorders.</description>
 <pubDate>04 Aug 2026 14:54:48 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/proteomic-meta-analysis-paints-landscape-neurological-markers#comments</comments>
</item>
<item>
 <title>Cognitively Sharp Centenarians Sidestep Tau Pathology</title>
 <link>https://www.alzforum.org/news/conference-coverage/cognitively-sharp-centenarians-sidestep-tau-pathology</link>
 <description>Despite an amyloid burden on par with Alzheimer&#039;s disease, many centenarians keep tau tangles at bay.</description>
 <pubDate>04 Aug 2026 10:17:04 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/cognitively-sharp-centenarians-sidestep-tau-pathology#comments</comments>
</item>
<item>
 <title>As Immunotherapy Use Grows, U.S. Clinics Innovate to Handle the Load</title>
 <link>https://www.alzforum.org/news/conference-coverage/immunotherapy-use-grows-us-clinics-innovate-handle-load</link>
 <description>Greater reliance on trained nurses and primary care, as well as the availability of subcutaneous lecanemab, may help accommodate growing caseloads.</description>
 <pubDate>31 Jul 2026 17:38:42 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/immunotherapy-use-grows-us-clinics-innovate-handle-load#comments</comments>
</item>
<item>
 <title>In China and U.S. Real-World Use, Leqembi Seems to Stabilize Cognition</title>
 <link>https://www.alzforum.org/news/conference-coverage/china-and-us-real-world-use-leqembi-seems-stabilize-cognition</link>
 <description>As cohorts expand, with a few people reaching three years on drug, accumulating data suggests their Alzheimer’s disease has slowed.</description>
 <pubDate>31 Jul 2026 16:12:26 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/china-and-us-real-world-use-leqembi-seems-stabilize-cognition#comments</comments>
</item>
<item>
 <title>De-Risking Donanemab: Dosing Tweak Cuts ARIA; Steroids, Not so Much</title>
 <link>https://www.alzforum.org/news/conference-coverage/de-risking-donanemab-dosing-tweak-cuts-aria-steroids-not-so-much</link>
 <description>As cohorts expand, with a few people reaching three years on drug, accumulating data suggests their Alzheimer’s disease has slowed.</description>
 <pubDate>31 Jul 2026 13:10:21 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/de-risking-donanemab-dosing-tweak-cuts-aria-steroids-not-so-much#comments</comments>
</item>
<item>
 <title>Plasma P-Tau217 Test Improves Diagnosis, Clinician Confidence </title>
 <link>https://www.alzforum.org/news/conference-coverage/plasma-p-tau217-test-improves-diagnosis-clinician-confidence</link>
 <description>In primary and secondary care in Sweden, the blood test led to changes in diagnosis and disease management. </description>
 <pubDate>30 Jul 2026 18:03:50 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/plasma-p-tau217-test-improves-diagnosis-clinician-confidence#comments</comments>
</item>
<item>
 <title>Scientists Chart Tau Modifications as Alzheimer’s Advances</title>
 <link>https://www.alzforum.org/news/conference-coverage/scientists-chart-tau-modifications-alzheimers-advances</link>
 <description>At AAIC, scientists map the myriad of post-translational modifications tau accrues through pathology stages. One goal: new biomarkers.</description>
 <pubDate>28 Jul 2026 15:43:59 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/scientists-chart-tau-modifications-alzheimers-advances#comments</comments>
</item>
<item>
 <title>Can P-Tau217 Predict Alzheimer’s Symptoms in Healthy People?</title>
 <link>https://www.alzforum.org/news/conference-coverage/can-p-tau217-predict-alzheimers-symptoms-healthy-people</link>
 <description>Data shown at AAIC suggests that the plasma marker helps determine whose cognition will decline within two to 10 years. But no slam dunk.</description>
 <pubDate>28 Jul 2026 13:27:58 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/can-p-tau217-predict-alzheimers-symptoms-healthy-people#comments</comments>
</item>
<item>
 <title>PrevenTRON and Beyond</title>
 <link>https://www.alzforum.org/news/conference-coverage/preventron-and-beyond</link>
 <description>A secondary prevention trial evaluating trontinemab’s ability to keep symptoms at bay in people with brain amyloid deposition will start later this year.  </description>
 <pubDate>24 Jul 2026 17:24:29 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/preventron-and-beyond#comments</comments>
</item>
<item>
 <title>In Open-Label Extension, Trontinemab Keeps Amyloid at Bay</title>
 <link>https://www.alzforum.org/news/conference-coverage/open-label-extension-trontinemab-keeps-amyloid-bay</link>
 <description>In Phase 2 OLE, brain amyloid dropped further below threshold of positivity, plasma kept going down GFAP. Phase 3 trials are enrolling. </description>
 <pubDate>24 Jul 2026 17:01:08 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/open-label-extension-trontinemab-keeps-amyloid-bay#comments</comments>
</item>
<item>
 <title>TSPO in FTD: A Marker of Microglia Munching Myelin?</title>
 <link>https://www.alzforum.org/news/conference-coverage/tspo-ftd-marker-microglia-munching-myelin</link>
 <description>At AAIC, researchers report that TSPO-PET signals in frontotemporal dementia come from phagocytic microglia amassing in white matter. </description>
 <pubDate>24 Jul 2026 14:03:47 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/tspo-ftd-marker-microglia-munching-myelin#comments</comments>
</item>
<item>
 <title>C-BRAIN Releases Its First Four AI Tools to Alzheimer’s Scientists </title>
 <link>https://www.alzforum.org/news/conference-coverage/c-brain-releases-its-first-four-ai-tools-alzheimers-scientists</link>
 <description>The open-source tools are still in development. C-BRAIN has opened them to the scientific community to try them and offer feedback. </description>
 <pubDate>24 Jul 2026 12:33:41 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/c-brain-releases-its-first-four-ai-tools-alzheimers-scientists#comments</comments>
</item>
<item>
 <title>Longitudinal PET Scans Reveal Amyloid Immunotherapy Use</title>
 <link>https://www.alzforum.org/news/conference-coverage/longitudinal-pet-scans-reveal-amyloid-immunotherapy-use</link>
 <description>In an observational study, marked drops in brain amyloid flagged people who, unbeknownst to investigators, had started anti-amyloid therapy.</description>
 <pubDate>22 Jul 2026 18:53:50 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/longitudinal-pet-scans-reveal-amyloid-immunotherapy-use#comments</comments>
</item>
<item>
 <title>Tau ASO Phase 2 Data Draw Crowd, Mixed Reactions</title>
 <link>https://www.alzforum.org/news/conference-coverage/tau-aso-phase-2-data-draw-crowd-mixed-reactions</link>
 <description>At AAIC, Biogen presented diranersen data. Despite missing its endpoint, the drug showed enough target engagement and cognitive benefit to go to Phase 3.</description>
 <pubDate>22 Jul 2026 18:47:06 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/tau-aso-phase-2-data-draw-crowd-mixed-reactions#comments</comments>
</item>
<item>
 <title>Two New Ways to Attack TDP-43</title>
 <link>https://www.alzforum.org/news/research-news/two-new-ways-attack-tdp-43</link>
 <description>A molecule that binds TDP-43 extends survival in ALS mice. Interrupting steric zippers stops aggregation of a short TDP-43 isoform; alters RNA splicing.</description>
 <pubDate>18 Jul 2026 19:54:47 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/two-new-ways-attack-tdp-43#comments</comments>
</item>
<item>
 <title>Does Tau Board Capsids to Sail Across Synapses? </title>
 <link>https://www.alzforum.org/news/research-news/does-tau-board-capsids-sail-across-synapses</link>
 <description>The synaptic plasticity protein Arc—an evolutionary cousin to viral capsids—escorts tau into extracellular vesicles. Lentiviruses carry seed-competent tau between cells. </description>
 <pubDate>17 Jul 2026 19:09:15 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/does-tau-board-capsids-sail-across-synapses#comments</comments>
</item>
<item>
 <title>Minus TDP-43, Microglia Fumble Myelin Cleanup</title>
 <link>https://www.alzforum.org/news/research-news/minus-tdp-43-microglia-fumble-myelin-cleanup</link>
 <description>Depleting TDP-43 in microglia causes the TREM2 partner Tyrobp to pick up a cryptic exon, hobbling signals managing myelin.</description>
 <pubDate>16 Jul 2026 14:07:05 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/minus-tdp-43-microglia-fumble-myelin-cleanup#comments</comments>
</item>
<item>
 <title>Massive Meta-Analysis Pegs Centiloid Positivity Thresholds</title>
 <link>https://www.alzforum.org/news/research-news/massive-meta-analysis-pegs-centiloid-positivity-thresholds</link>
 <description>Data from 50,000 people identified18 centiloids as the best single cutoff, 11 and 26 as the best double cutoffs. </description>
 <pubDate>16 Jul 2026 11:05:13 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/massive-meta-analysis-pegs-centiloid-positivity-thresholds#comments</comments>
</item>
<item>
 <title>Does APOE4 Act Through Oligodendrocytes?</title>
 <link>https://www.alzforum.org/news/research-news/does-apoe4-act-through-oligodendrocytes</link>
 <description>Both X-linked and cell-type GWAS suggest that APOE4 perturbs myelination, particularly in women, offering a clue to their higher AD risk.</description>
 <pubDate>11 Jul 2026 07:15:21 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/does-apoe4-act-through-oligodendrocytes#comments</comments>
</item>
<item>
 <title>Immune Shocker—In Mouse Brain, B Cells Drive Synaptic Pruning</title>
 <link>https://www.alzforum.org/news/research-news/immune-shocker-mouse-brain-b-cells-drive-synaptic-pruning</link>
 <description>Frenzied neuronal activity recruits B cells. IgMs combine with complement to mark synapses for pruning. In an AD model, dampening neuronal firing stymies synaptic loss.</description>
 <pubDate>09 Jul 2026 18:12:03 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/immune-shocker-mouse-brain-b-cells-drive-synaptic-pruning#comments</comments>
</item>
<item>
 <title>Before Succumbing to ALS, Neurons Descend into Disease State</title>
 <link>https://www.alzforum.org/news/research-news/succumbing-als-neurons-descend-disease-state</link>
 <description>As disease worsens, alpha motor neurons increasingly transition into a newly identified state, featuring a mix of protective and degenerative signals. </description>
 <pubDate>09 Jul 2026 15:48:31 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/succumbing-als-neurons-descend-disease-state#comments</comments>
</item>
<item>
 <title>Proteome-wide Association Study Points to New Alzheimer&#039;s Genes</title>
 <link>https://www.alzforum.org/news/research-news/proteome-wide-association-study-points-new-alzheimers-genes</link>
 <description>Plasma PWAS identifies 18 AD risk genes that regulate abundance of proteins in plasma. Three are new.  </description>
 <pubDate>05 Jul 2026 10:49:45 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/proteome-wide-association-study-points-new-alzheimers-genes#comments</comments>
</item>
<item>
 <title>Rare Variants Offer Clues to APOE Toxicity: Lipidation, Aggregation</title>
 <link>https://www.alzforum.org/news/research-news/rare-variants-offer-clues-apoe-toxicity-lipidation-aggregation</link>
 <description>A new protective variant, W276C, lowers ApoE’s propensity to aggregate, while risk variant R189C boosts its lipidation, messing up microglial metabolism.</description>
 <pubDate>02 Jul 2026 18:06:19 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/rare-variants-offer-clues-apoe-toxicity-lipidation-aggregation#comments</comments>
</item>
<item>
 <title>Membrane Fix-a-Flat? FTD Proteins Patch Cell Surface</title>
 <link>https://www.alzforum.org/news/research-news/membrane-fix-flat-ftd-proteins-patch-cell-surface</link>
 <description>Annexin-A11 forms a temporary plug, then the ESCRT-III complex pinches it off to finish the repair. </description>
 <pubDate>02 Jul 2026 11:49:58 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/membrane-fix-flat-ftd-proteins-patch-cell-surface#comments</comments>
</item>
<item>
 <title>Low CSF TMEM106B: Sign of Disease, or Just Good Genes?</title>
 <link>https://www.alzforum.org/news/research-news/low-csf-tmem106b-sign-disease-or-just-good-genes</link>
 <description>People with frontotemporal dementia or Alzheimer’s disease have less TMEM106B in their cerebrospinal fluid. But so do people who carry a protective variant.</description>
 <pubDate>01 Jul 2026 18:09:54 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/low-csf-tmem106b-sign-disease-or-just-good-genes#comments</comments>
</item>
<item>
 <title>Amyloid Stokes Toxic mRNA from Mitochondria, and Inflammation Flares</title>
 <link>https://www.alzforum.org/news/research-news/amyloid-stokes-toxic-mrna-mitochondria-and-inflammation-flares</link>
 <description>Under healthy conditions, neurons degrade mitochondrial mRNA that leaks into the cytosol. Not when amyloid is around.</description>
 <pubDate>26 Jun 2026 16:28:07 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/amyloid-stokes-toxic-mrna-mitochondria-and-inflammation-flares#comments</comments>
</item>
<item>
 <title>Plasma Proteome Offers Clues to Risk and Resilience in APOE4 Carriers</title>
 <link>https://www.alzforum.org/news/research-news/plasma-proteome-offers-clues-risk-and-resilience-apoe4-carriers</link>
 <description>APOE2 and APOE4 carriers have distinct profiles that are not simple opposites. APOE4 carriers who keep their memories sharp express protective genes.</description>
 <pubDate>26 Jun 2026 12:37:14 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/plasma-proteome-offers-clues-risk-and-resilience-apoe4-carriers#comments</comments>
</item>
</channel>
</rss>
